| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate |
2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e88aec6523bd081a173f915369ab3e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7c8473cd64b1a7fb44fef5bf5fdf9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754e1801a97f6af44bd3a9390f0b7fb0 |
| publicationDate |
2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2009011268-A |
| titleOfInvention |
FIBRINE COMPOSITIONS CONTAINING STRONTIUM COMPOUNDS. |
| abstract |
The present invention relates to a composition for use in bone healing and bone regeneration in the form of a visoelastic hydrogel gel or liquid formulation comprising fibrinogen, thrombin and an inorganic component comprising a strontium-containing compound (Sr) and / or possibly another metal such as a calcium containing compound. The strontium-containing compound can be dissolved in thrombin solutions or added to the clot in crystalline particulate form. In the mixing of the components, gelation takes place to form a matrix. The composition may also comprise a compound containing iodine which acts as a plasticizer. |
| priorityDate |
2007-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |